Skip to main content
Clinical Trials/CTRI/2021/07/034624
CTRI/2021/07/034624
Recruiting
未知

A prospective open label clinical trial to evaluate the topical viral load reduction potential of PROTECT-C hand sanitizer on SARS-CoV-2 infected subjects. - Nil

MIYAKAWA KOGYO INDIA PVT LTD0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
MIYAKAWA KOGYO INDIA PVT LTD
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
MIYAKAWA KOGYO INDIA PVT LTD

Eligibility Criteria

Inclusion Criteria

  • Tested SARS\- CoV\-2 positive within last 8 days of study enrolment.
  • Patients willing to sign written informed consent and are ready to comply to study procedure.
  • SARS\-CoV\-2 positive asymptomatic or symptomatic patients who are under institutional quarantine/ home isolated/ hospitalized.

Exclusion Criteria

  • Patients on ventilator support. Pregnant or lactating woman. Subjects with history of sun burn on hands. Subjects with history of skin disorders or on medication for the same: Eczema, Urticaria, Psoriasis, Herpes, skin cancer, Lupus, Vitiligo, Fungal infection, Candidiasis. Subjects on treatment of any degree burns. Any kind of psychiatric disorder or a condition in the opinion of the investigator may hinder communication with the research team. Inability of the subject to cooperate or communicate with the research team and provide follow up.

Outcomes

Primary Outcomes

Not specified

Similar Trials